The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor mutation burden and PIK3CA mutations are associated with pathological complete response in human epidermal growth factor receptor 2-positive breast cancer patients receiving pyrotinib combined with trastuzumab neoadjuvant treatment.
 
Qiyun Shi
No Relationships to Disclose
 
Juncheng Xuhong
No Relationships to Disclose
 
Jia Ge
No Relationships to Disclose
 
Feng Liu
No Relationships to Disclose
 
Yang Lan
No Relationships to Disclose
 
Yi Zhang
No Relationships to Disclose
 
Tao Luo
No Relationships to Disclose
 
Xiuwu Bian
No Relationships to Disclose
 
Xiaowei Qi
No Relationships to Disclose
 
Jun Jiang
No Relationships to Disclose